We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Forges Ahead With Expanded Generic Sovaldi Licensing in Developing Countries
Gilead Forges Ahead With Expanded Generic Sovaldi Licensing in Developing Countries
Gilead has expanded its licensing agreements with eight India-based generic drugmakers to market cheaper copies of its pricey blockbuster hepatitis C therapy Sovaldi in 91 developing countries.